Profile
PRVB VRTX REGN VRNA ARGX ALNY
Company Name Provention Bio, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $2.38B $122.53B $81.42B $72.68B $51.58B $43.35B
Employees 0.17K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Ashleigh W. Palmer Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
PRVB VRTX REGN VRNA ARGX ALNY
Quant Rating Score 3 4 4 1 4 3
Quant Rating Neutral Buy Buy Strong Sell Buy Neutral
Trading
PRVB VRTX REGN VRNA ARGX ALNY
Last Close $24.98 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $24.98 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $24.98 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High 0 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 0 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
PRVB VRTX REGN VRNA ARGX ALNY
1 Month Return 0 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return 0 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return 0 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return 0 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return 0 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return 0 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
PRVB VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.45 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -94.85 % 9.76 % 3.92 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 8.22 % - - -
Profitability
PRVB VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM 96.03 % 86.28 % 86.27 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -47.95 % 14.78 % 11.11 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM 133.43 % 21.81 % 14.83 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM -87.5 % 19.59 % 10.3 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 89.45 % 82.61 % 86.12 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 99.06 % 111.4 % 146.19 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM -993.88 % 34.06 % 24.95 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM -315.38 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM 9.49 6.02 2.5 1.93 1.91 3.33
Payables Turnover TTM 0.08 0.4 2.1 2.37 0.9 4.37
Inventory Turnover TTM 0.42 0.99 0.62 0.94 2.26 6.82
Fixed Asset Turnover TTM 510.49 % 388.59 % 280.11 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM 5.44 % 47.15 % 35.36 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -1.01 14.55 48.39 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -1.02 13.06 39.66 -0.85 5.58 1.68
Cash Per Share TTM 220.82 % 2459.7 % 8362.68 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM -584.78 % 31.71 % 34.71 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 101.05 % 89.76 % 81.96 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM -315.38 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -31.17 36.72 19.95 -995.27 129.37 195.85
Price To Operating Cash Flows Ratio TTM -24.75 32.86 16.2 -126.33 146.05 162.25
Price Cash Flow Ratio TTM -24.75 32.86 16.2 -126.33 146.05 162.25
Income Statement (TTM)
PRVB VRTX REGN VRNA ARGX ALNY
Revenue $0.01B $12B $14.34B $0.03B $2.19B $3.71B
Gross Profit $0.01B $10.35B $12.24B $0.03B $1.96B $3.04B
Gross Profit Ratio 96.03% 86.24% 85.35% 93.89% 89.62% 81.77%
EBITDA $-0.12B $4.69B $5.82B $-0.12B $0.11B $0.56B
Net Income $-0.11B $3.95B $4.5B $-0.14B $0.83B $0.31B
EPS Diluted -1.52 15.32 41.48 -1.73 12.78 2.33
Balance Sheet (MRQ)
PRVB VRTX REGN VRNA ARGX ALNY
Long Term Debt $0.02B $3.69B $2.71B $0.12B $0.03B $2.7B
Total Liabilities $0.12B $6.98B $9.3B $0.27B $0.7B $4.18B
Total Equity $0.12B $18.67B $31.26B $0.2B $5.5B $0.79B
Total Investments $0.12B $5.71B $15.75B $0.02B $1.93B $1.25B
Total Debt $0.02B $3.69B $2.71B $0.12B $0.04B $2.97B
Total Assets $0.24B $25.64B $40.56B $0.47B $6.2B $4.97B
Cash Flow Statement (TTM)
PRVB VRTX REGN VRNA ARGX ALNY
Net Income $-0.11B $3.95B $4.5B $-0.17B $0.83B $0.31B
Inventory $-0B $-0.52B $-0.28B $-0.01B $-0.1B $0.01B
Dividends Paid $0B $0B $-0.37B $0B $0B $0B
Operating Cash Flow $-0.08B $3.63B $4.98B $-0.12B $-0.08B $0.52B
Capital Expenditure $-0B $-0.44B $-0.9B $-0B $-0.07B $-0.06B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 23.82
AARD Aardvark Therapeutics, Inc. Common Stock 12.1
ABCL AbCellera Biologics Inc. 3.1
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.01
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.51
ABPWW 0.0131
ABSI Absci Corporation 2.55
ABUS Arbutus Biopharma Corporation 3.98
ABVC ABVC BioPharma, Inc. 1.67
ABVX Abivax SA American Depositary Shares 124.99
ACAD ACADIA Pharmaceuticals Inc. 22.03
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 6.91
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.2
ACIU AC Immune SA 2.99
ETFs With Exposure to PRVB
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.02 262.96
IBB iShares Biotechnology ETF 0.06 172.5
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 149.23
NUV Nuveen Municipal Value Fund, Inc. 0.14 9.2
IWN iShares Russell 2000 Value ETF 0.01 199.97
IWV iShares Russell 3000 ETF 0 388.3
NVG Nuveen AMT-Free Municipal Credit Income Fund 0.14 13.37
IWO iShares Russell 2000 Growth ETF 0.04 334.76
BIB ProShares Ultra Nasdaq Biotechnology 0.06 84.7191
HDG ProShares Hedge Replication ETF 0.01 52.7
UWM ProShares Ultra Russell2000 0.03 53.08
XPH SPDR S&P Pharmaceuticals ETF 3.3 56.84
ONEQ Fidelity Nasdaq Composite Index ETF 0.03 88.7542
IWC iShares Micro-Cap ETF 0.13 166.03
DWAS Invesco DWA SmallCap Momentum ETF 1 100.36
FHLC Fidelity MSCI Health Care Index ETF 0.0117421 74.96
URTY ProShares UltraPro Russell2000 0.02 63.07
VTWV Vanguard Russell 2000 Value Index Fund 0.02 176.213
PILL Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF 0.67 12.44
BTEC Principal Healthcare Innovators ETF 0.58 39.49
MRGR ProShares Merger ETF 2.31 44.765
NUSC Nuveen ESG Small-Cap ETF 0.14 47.98
NUW Nuveen AMT-Free Municipal Value Fund 0.14 14.43
PBSM Invesco PureBeta MSCI USA Small Cap ETF 0.05 31.9152
PTH Invesco DWA Healthcare Momentum ETF 4.18 48.1257
VFMO Vanguard U.S. Momentum Factor ETF 0.09 205.14
VTWG Vanguard Russell 2000 Growth Index Fund 0.1 244.5
DWMC AdvisorShares Dorsey Wright Micro-Cap ETF 0.42 30.95
VQNPX Vanguard Growth and Income Fund 0 66.74
VGIAX Vanguard Quantitative Funds - Vanguard Growth and Income Fund 0 108.9
SPGM SPDR Portfolio MSCI Global Stock Market ETF 0.01 79.67
ESML iShares ESG Aware MSCI USA Small-Cap ETF 0.1 49.69
IEIH iShares Evolved U.S. Innovative Healthcare ETF 0.02 34.1348
RYLD Global X Russell 2000 Covered Call ETF 0.05 15.69
AVUS Avantis U.S. Equity ETF 0 115.98
IBBQ Invesco Nasdaq Biotechnology ETF 0.19 29.429
DFAS Dimensional U.S. Small Cap ETF 0 75.67
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.19357 7.345
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.05 8.7175
WSML.L iShares MSCI World Small Cap UCITS ETF 0.02 9.853
IUSN.DE iShares MSCI World Small Cap UCITS ETF 0.0635 8.3
SXRG.DE iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced UCITS ETF USD (Acc) 0.17389 536.2
DRDR.L iShares Healthcare Innovation UCITS ETF 0.07 667.75
WLDS.L iShares MSCI World Small Cap UCITS ETF 0.02 7.229
2B78.DE iShares Healthcare Innovation UCITS ETF 0.25432 7.667
JKK iShares Morningstar Small-Cap Growth ETF 0.01 307.42
JKJ iShares Morningstar Small-Cap ETF 0.01 231.193
JKL iShares Morningstar Small-Cap Value ETF 0.01 172.726
CBUG.DE iShares MSCI World Small Cap ESG Enhanced UCITS ETF 0.14586 5.574
Unlock